Journal IJCRT UGC-CARE, UGCCARE( ISSN: 2320-2882 ) | UGC Approved Journal | UGC Journal | UGC CARE Journal | UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, International Peer Reviewed Journal and Refereed Journal, ugc approved journal, UGC CARE, UGC CARE list, UGC CARE list of Journal, UGCCARE, care journal list, UGC-CARE list, New UGC-CARE Reference List, New ugc care journal list, Research Journal, Research Journal Publication, Research Paper, Low cost research journal, Free of cost paper publication in Research Journal, High impact factor journal, Journal, Research paper journal, UGC CARE journal, UGC CARE Journals, ugc care list of journal, ugc approved list, ugc approved list of journal, Follow ugc approved journal, UGC CARE Journal, ugc approved list of journal, ugc care journal, UGC CARE list, UGC-CARE, care journal, UGC-CARE list, Journal publication, ISSN approved, Research journal, research paper, research paper publication, research journal publication, high impact factor, free publication, index journal, publish paper, publish Research paper, low cost publication, ugc approved journal, UGC CARE, ugc approved list of journal, ugc care journal, UGC CARE list, UGCCARE, care journal, UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, ugc care list of journal, ugc care list 2020, ugc care approved journal, ugc care list 2020, new ugc approved journal in 2020, ugc care list 2021, ugc approved journal in 2021, Scopus, web of Science.
How start New Journal & software Book & Thesis Publications
Submit Your Paper
Login to Author Home
Communication Guidelines

WhatsApp Contact
Click Here

  Published Paper Details:

  Paper Title

Metformin in the management of Type 2 diabetic mellitus

  Authors

  Prajval V.Tidke,  Suraj S.Raut,  Vinayak A.Katekar,  Dr. Swati P.Deshmukh

  Keywords

Keywords -Hypoglycemic,Antidiabetic,Metformin,AMP-activated protein kinase (AMPK),Type 2 diabetes,Hyperglycemia.

  Abstract


Abstract - Metformin, a broadly endorsed verbal hypoglycemic operator, plays a essential part within the administration of diabetes mellitus. This theoretical investigates the multifaceted impacts of metformin on glucose digestion system, affront affectability, and its affect on different metabolic pathways. As a first-line treatment for sort 2 diabetes, metformin basically targets hepatic gluconeogenesis, decreasing glucose generation and advancing fringe glucose take-up. Its special component of activity includes actuation of AMP-activated protein kinase (AMPK), driving to progressed cellular vitality adjust.Past glycemic control, metformin appears pleiotropic impacts, checking adjust of lipid assimilation framework and anti-inflammatory properties. Its potential benefits extend past glycemic control, with considers almost proposing cardiovascular affirmation and a diminish inside the recurrence of diabetes-related complications. Be that because it may, concerns around metformin's tolerability and exceptional unfavorable impacts, such as lactic acidosis, warrant cautious diligent choice and checking.In spite of its built up adequacy, continuous inquire about points to unwind metformin's broader restorative potential, investigating its affect on maturing and cancer. This unique underscores metformin's central part in diabetes administration, emphasizing its comprehensive impacts on metabolic pathways and highlighting its advancing part within the broader range of wellbeing and illness.

  IJCRT's Publication Details

  Unique Identification Number - IJCRT2401643

  Paper ID - 250071

  Page Number(s) - f397-f403

  Pubished in - Volume 12 | Issue 1 | January 2024

  DOI (Digital Object Identifier) -   

  Publisher Name - IJCRT | www.ijcrt.org | ISSN : 2320-2882

  E-ISSN Number - 2320-2882

  Cite this article

  Prajval V.Tidke,  Suraj S.Raut,  Vinayak A.Katekar,  Dr. Swati P.Deshmukh,   "Metformin in the management of Type 2 diabetic mellitus", International Journal of Creative Research Thoughts (IJCRT), ISSN:2320-2882, Volume.12, Issue 1, pp.f397-f403, January 2024, Available at :http://www.ijcrt.org/papers/IJCRT2401643.pdf

  Share this article

  Article Preview

  Indexing Partners

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
Call For Paper July 2024
Indexing Partner
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
DOI Details

Providing A Free digital object identifier by DOI.one How to get DOI?
For Reviewer /Referral (RMS) Earn 500 per paper
Our Social Link
Open Access
This material is Open Knowledge
This material is Open Data
This material is Open Content
Indexing Partner

Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer